Astaxanthin untuk Kesehatan Kardiovaskular
Abstract
Penyakit kardiovaskular adalah penyebab utama kematian di seluruh dunia. Adanya dislipidemia, gangguan toleransi glukosa, dan hipertensi dengan akumulasi lemak visceral yang disebut sindrom metabolik, meningkatkan risiko penyakit kardiovaskular. Sindrom metabolik sering ditandai dengan stres oksidatif, gangguan keseimbangan antara produksi reactive oxygen species dan pertahanan antioksidan. Sementara itu, astaxanthine diketahui memiliki karakteristik antioksidan yang kuat, yang telah dilaporkan melampaui karakteristik β-karoten atau bahkan α-tokoferol. Penelitian ini merupakan literature review yang melibatkan sebanyak 20 sumber pustaka dengan kata kunci yang digunakan antara lain ‘astaxanthin, cardiovascular disease dan xanthophyll carotenoid’ dengan tahun terbit antara 2006-2020. Abstrak dan full text jurnal dibaca dan dicermati, kemudian dilakukan analisis terhadap isi yang terdapat dalam tujuan penelitian dan hasil/temuan penelitian. Beberapa penelitian menunjukkan adanya beberapa manfaat yang dapat secara langsung atau tidak langsung dari astaxanthin berkaitan dengan potensi antioksidannya, termasuk kemampuannya untuk mengurangi atau menetralkan produksi ROS, sehingga meningkatkan aktivitas enzim pembersih radikal. Astaxanthin juga berperan sebagai anti inflamasi dan berperan dalam metabolisme lipid melalui efek hipokolesterolemik serta melindungi dari iskemia reperfusi. Astaxanthin di ketahui dapat memberikan manfaat bagi kesehatan kardiovaskular melalui berbagai mekanisme seperti peran antioksidan yang lebih baik, anti inflamasi, efek hipokolesterolemik dalam metabolisme lipid dan melindungi dari iskemia reperfusi.
References
Alam, M. N., Hossain, M. M., Rahman, M. M., Subhan, N., Mamun, M. A. Al, Ulla, A., Reza, H. M., & Alam, M. A. (2018). Astaxanthin Prevented Oxidative Stress in Heart and Kidneys of Isoproterenol-Administered Aged Rats. Journal of Dietary Supplements, 15(1), 42–54. https://doi.org/10.1080/19390211.2017.1321078
Bhuvaneswari, S., Arunkumar, E., Viswanathan, P., & Anuradha, C. V. (2010). Astaxanthin restricts weight gain, promotes insulin sensitivity and curtails fatty liver disease in mice fed a obesity-promoting diet. Process Biochemistry, 45(8), 1406–1414. https://doi.org/10.1016/j.procbio.2010.05.016
Choi, H. D., Kim, J. H., Chang, M. J., Kyu-Youn, Y., & Shin, W. G. (2011). Effects of astaxanthin on oxidative stress in overweight and obese adults. Phytotherapy Research, 25(12), 1813–1818. https://doi.org/10.1002/ptr.3494
Curek, G. D., Cort, A., Yucel, G., Demir, N., Ozturk, S., Elpek, G. O., Savas, B., & Aslan, M. (2010). Effect of astaxanthin on hepatocellular injury following ischemia/reperfusion. Toxicology, 267(1–3), 147–153. https://doi.org/10.1016/j.tox.2009.11.003
Deng, Z. Y., Shan, W. G., Wang, S. F., Hu, M. M., & Chen, Y. (2017). Effects of astaxanthin on blood coagulation, fibrinolysis and platelet aggregation in hyperlipidemic rats. Pharmaceutical Biology, 55(1), 663–672. https://doi.org/10.1080/13880209.2016.1261905
Doughty, K. N., Del Pilar, N. X., Audette, A., & Katz, D. L. (2017). Lifestyle Medicine and the Management of Cardiovascular Disease. Current Cardiology Reports, 19(11). https://doi.org/10.1007/s11886-017-0925-z
Fassett, R. G., & Coombes, J. S. (2012). Astaxanthin in cardiovascular health and disease. Molecules, 17(2), 2030–2048. https://doi.org/10.3390/molecules17022030
Garcia-Arellano, A., Martínez-González, M. A., Ramallal, R., Salas-Salvadó, J., Hébert, J. R., Corella, D., Shivappa, N., Forga, L., Schröder, H., Muñoz-Bravo, C., Estruch, R., Fiol, M., Lapetra, J., Serra-Majem, L., Ros, E., Rekondo, J., Toledo, E., Razquin, C., Ruiz-Canela, M., … Sáez, G. (2019). Dietary inflammatory index and all-cause mortality in large cohorts: The SUN and PREDIMED studies. Clinical Nutrition, 38(3), 1221–1231. https://doi.org/10.1016/j.clnu.2018.05.003
Hussein, G., Goto, H., Oda, S., Sankawa, U., Matsumoto, K., & Watanabe, H. (2006). Antihypertensive potential and mechanism of action of astaxanthin: III. Antioxidant and histopathological effects in spontaneously hypertensive rats. Biological and Pharmaceutical Bulletin, 29(4), 684–688. https://doi.org/10.1248/bpb.29.684
Kishimoto, Y., Yoshida, H., & Kondo, K. (2016). Potential anti-atherosclerotic properties of astaxanthin. Marine Drugs, 14(2), 1–13. https://doi.org/10.3390/md14020035
Lanier, J. B., Bury, D. C., & Richardson, S. W. (2016). Diet and Physical Activity for Cardiovascular Disease Prevention. American Family Physician, 93(11), 919–924.
Li, J., Wang, F., Xia, Y., Dai, W., Chen, K., Li, S., Liu, T., Zheng, Y., Wang, J., Lu, W., Zhou, Y., Yin, Q., Lu, J., Zhou, Y., & Guo, C. (2015). Astaxanthin pretreatment attenuates hepatic ischemia reperfusion-induced apoptosis and autophagy via the ROS/MAPK pathway in mice. Marine Drugs, 13(6), 3368–3387. https://doi.org/10.3390/md13063368
MacEdo, R. C., Bolin, A. P., Marin, D. P., & Otton, R. (2010). Astaxanthin addition improves human neutrophils function: In vitro study. European Journal of Nutrition, 49(8), 447–457. https://doi.org/10.1007/s00394-010-0103-1
Migliaccio, S., Brasacchio, C., Pivari, F., Salzano, C., Barrea, L., Muscogiuri, G., Savastano, S., & Colao, A. (2020). What is the best diet for cardiovascular wellness? A comparison of different nutritional models. International Journal of Obesity Supplements, 10(1), 50–61. https://doi.org/10.1038/s41367-020-0018-0
Ni, Y., Nagashimada, M., Zhuge, F., Zhan, L., Nagata, N., Tsutsui, A., Nakanuma, Y., Kaneko, S., & Ota, T. (2015). Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: A comparison with Vitamin E. Scientific Reports, 5(October), 1–15. https://doi.org/10.1038/srep17192
Salim, K. P., Indrawati, R., & Limantara, L. (2016). Terapi Alternatif Penyakit Kardiovaskular dengan Pigmen Alami. 43(11), 871–874.
Santos, S. D., Cahú, T. B., Firmino, G. O., de Castro, C. C. M. M. B., Carvalho, L. B., Bezerra, R. S., & Filho, J. L. L. (2012). Shrimp Waste Extract and Astaxanthin: Rat Alveolar Macrophage, Oxidative Stress and Inflammation. Journal of Food Science, 77(7). https://doi.org/10.1111/j.1750-3841.2012.02762.x
Tsai, M. C., Huang, S. C., Chang, W. T., Chen, S. C., & Hsu, C. L. (2020). Effect of astaxanthin on the inhibition of lipid accumulation in 3T3-L1 adipocytes via modulation of lipogenesis and fatty acid transport pathways. Molecules, 25(16), 1–12. https://doi.org/10.3390/molecules25163598
Xia, W., Tang, N., Kord-Varkaneh, H., Low, T. Y., Tan, S. C., Wu, X., & Zhu, Y. (2020). The effects of astaxanthin supplementation on obesity, blood pressure, CRP, glycemic biomarkers, and lipid profile: A meta-analysis of randomized controlled trials. Pharmacological Research, 161(March), 105113. https://doi.org/10.1016/j.phrs.2020.105113
Yang, Y., Seo, J. M., Nguyen, A., Pham, T. X., Park, H. J., Park, Y., Kim, B., Bruno, R. S., & Lee, J. (2011). Astaxanthin-rich extract from the green alga Haematococcus pluvialis lowers plasma lipid concentrations and enhances antioxidant defense in apolipoprotein E knockout mice. Journal of Nutrition, 141(9), 1611–1617. https://doi.org/10.3945/jn.111.142109



